악성흉막중피종의 병기판정에서 자기공명영상의 진단적 유용성 평가
Added Value of Magnetic Resonance Imaging in Staging of Malignant Pleural Mesothelioma
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
목적 : 악성흉막중피종 (이하 MPM)의 임상적 병기판정에 있어 자기공명영상 (이하 MR)의 진단적 유용성을 컴퓨터단층촬영(이하 CT)과 비교하였다. 대상 및 방법 : 1997년부터 2012년까지 MPM으로 확인된 환자 중 진단 시 CT와 MR을 얻은 환자 20명 (남:여=14:6; 평균연령= 53.5세)을 대상으로 하였다. CT 혹은 MR 단독을 이용하여 두 명의 영상의학과 의사가 의견 일치 하에 병기판정을시행하였다. 수술적 병기판정을 받은 환자의 경우 이와 비교하여 CT 단독 및 CT와 MR을 함께 시행하였을 때의 진단적 정확도를 평가하였다. 또 CT 단독과 CT와 MR을 함께 시행하였을 때의 임상병기의 일치도를 비교하였다. 결과 : CT를 이용한 T stage의 정확도는 23.1% (3/13)였고 MR과 함께 시행한 경우 38.5% (5/13)였다. CT 및 MR을함께 시행한 경우 수술 후 수술적 병기에서 5명의 환자는 상위 진단을, 3명의 환자는 하위 진단을 보였다. CT 단독 및 CT와MR을 함께 시행한 병기를 서로 비교하였을 때 85.0% (17/20)의 일치도를 보였고 불일치한 예(3명)에서는 함께 시행한경우 CT 단독보다 상위 진단을 하였다. 결론 : MPM의 병기판정에 있어서 MR을 함께 시행한 경우 CT 단독에 비해 보다 높은 정확도의 병기판정을 제공하여 수술대상이 되는 환자에서 수술 전 검사로서 중요한 역할을 수행할 것으로 기대된다.
Abstract
Purpose : We investigated the possible added value of magnetic resonance imaging (MR) in staging of malignant pleural mesothelioma (MPM) compared to computed tomography (CT). Materials and Methods: We retrospectively enrolled 20 patients (M;F = 14:6; mean age, 53.5 yrs) who diagnosed as MPM by histology and underwent CT and MR at initial evaluation from Jan 1997 to Dec 2012. Two radiologists performed clinical staging by using CT alone or MR alone in consensus. In patients underwent surgery (n = 13), we evaluated the diagnostic accuracy of CT and MR in terms of staging compared to surgical staging. In all patients,we compared clinical staging of CT only and CT with MR. Results: The diagnostic accuracy for T staging of CT only was 23.1% (3/13) and that of combined CT and MR was 38.5% (5/13), respectively. Among 13 patients underwent surgery, surgical stage was higher than combined CT and MR stage in 5 patients, but lower in 3 patients. CT only and combined CT and MR agreed in 85.0% (17/ 20). In cases of disagree (15.0%, 3/20), combined CT and MR showed higher stage than CT only. Conclusion: Combined CT and MR increases the diagnostic accuracy in staging of MPM compared to CT only and is important in determining the appropriate treatment in patients being considered for surgery.
참고문헌 (29)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010", Cancer Research and Treatment, 45(1), pp.1~14 (2013), 대한암학회
- Teta MJ, "US mesothelioma patterns 1973-2002: indicators of change and insights into background rates", Eur J Cancer Prev, 17, pp.525~534 (2008)
- Price B, "Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003", Am J Epidemiol, 159, pp.107~112 (2004)
- Delgermaa V, "Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008", Bull World Health Organ, 89, pp.716~724 (2011)
- Cao C, "Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma", Lung Cancer, 81, pp.319~327 (2013)
- Erasmus JJ, "Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications", J Thorac Cardiovasc Surg, 129, pp.1364~1370 (2005)
- Scherpereel A, "Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma", Eur Respir J, 35, pp.479~495 (2010)
- Martino D, "Integration of multimodality approaches in the management of malignant pleural mesothelioma", Clin Lung Cancer, 5, pp.290~298 (2004)
- Neumann V, "Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health", Dtsch Arztebl Int, 110, pp.319~326 (2013)
- Sugarbaker DJ, "Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients", J Thorac Cardiovasc Surg, 117, pp.54~63 (1999)
- Rusch V, "The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass.", J Thorac Cardiovasc Surg, 145, pp.909~910 (2013)
- Nowak AK., "CT, RECIST, and malignant pleural mesothelioma", Lung Cancer, 49(Suppl 1), pp.S37~S40 (2005)
- Patz EF, Jr., "Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability", AJR Am J Roentgenol, 159, pp.961~966 (1992)
- Heelan RT, "Staging of malignant pleural mesothelioma: comparison of CT and MR imaging", AJR Am J Roentgenol, 172, pp.1039~1047 (1999)
- Wang ZJ, "Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET", Radiographics, 24, pp.105~119 (2004)
- Boiselle PM, "Imaging of mediastinal lymph nodes: CT, MR, and FDG PET", Radiographics, 18, pp.1061~1069 (1998)
- Karabulut N, "MR imaging of the chest using a contrast-enhanced breath-hold modified threedimensional gradient-echo technique: comparison with twodimensional gradient-echo technique and multidetector CT", AJR Am J Roentgenol, 179, pp.1225~1233 (2002)
- Hintze C, "New procedures. Comprehensive staging of lung cancer by MRI", Radiologe, 50, pp.699~705 (2010)
- Kajiwara N, "Cine MRI enables better therapeutic planning than CT in cases of possible lung cancer chest wall invasion", Lung Cancer, 69, pp.203~208 (2010)
- Plathow C, "Computed tomography, positron emission tomography, positron emission tomography", computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results, 2008, pp.43, 737~744
- Zahid I, "What is the best way to diagnose and stage malignant pleural mesothelioma?", Interact Cardiovasc Thorac Surg, 12, pp.254~259 (2011)
- Rusch VW, "A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group", Chest, 108, pp.1122~1128 (1995)
- Treasure T, "Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study", Lancet Oncol, 12, pp.763~772 (2011)
- Datta A, "Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position", Thorax (2013)
- Gill RR, "Imaging of mesothelioma", Recent Results Cancer Res, 189, pp.27~43 (2011)
- Gill RR, "MR imaging of benign and malignant pleural disease", Magn Reson Imaging Clin N Am, 16, pp.319~339 (2008)
- Donmez FY, "Dynamic contrast enhancement patterns of solitary pulmonary nodules on 3D gradient-recalled echo MRI", AJR Am J Roentgenol, 189, pp.1380~1386 (2007)
- Lee VS, "Volumetric MR imaging of the liver and applications", Magn Reson Imaging Clin N Am, 9, pp.697~716 (2001)
- Weber U, "Anterior chest wall inflammation by whole-body magnetic resonance imaging in patients with spondyloarthritis: lack of association between clinical and imaging findings in a cross-sectional study", Arthritis Res Ther, 14, pp.R3~ (2012)